You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Aminophylline In Sodium Chloride 0.45% In Plastic Container patents expire, and what generic alternatives are available?

Aminophylline In Sodium Chloride 0.45% In Plastic Container is a drug marketed by Hospira and is included in one NDA.

The generic ingredient in AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER is aminophylline. There are four drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the aminophylline profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Aminophylline In Sodium Chloride 0.45% In Plastic Container

A generic version of AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER was approved as aminophylline by HOSPIRA on October 26th, 1983.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER?
  • What are the global sales for AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER?
  • What is Average Wholesale Price for AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER?
Summary for AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
Drug patent expirations by year for AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
Recent Clinical Trials for AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Mahidol UniversityPhase 2/Phase 3
University of OklahomaPhase 1/Phase 2
Medical College of WisconsinPhase 1/Phase 2

See all AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER clinical trials

US Patents and Regulatory Information for AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER aminophylline INJECTABLE;INJECTION 018924-001 Dec 12, 1984 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER aminophylline INJECTABLE;INJECTION 018924-004 Dec 12, 1984 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER aminophylline INJECTABLE;INJECTION 018924-002 Dec 12, 1984 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER aminophylline INJECTABLE;INJECTION 018924-003 Dec 12, 1984 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.